Sirona Biochem Begins Proof of Efficacy Clinical Trial for TFC-1067
CANADIAN DAILY STOCK REPORT
Corporate Wire Date: 06 November 2018 14:33 EST
ORIGINAL ANNOUNCEMENT [Text]
VANCOUVER, Nov. 6, 2018
VANCOUVER, Nov. 6, 2018 - Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (the "Company") reported today the successful launch of the clinical trial for skin-lightener TFC-1067 with leading dermatologist Dr. Zoe Draelos.
In September, Sirona reported that the Company was awaiting final results from the second clinical tr...